234
Views
6
CrossRef citations to date
0
Altmetric
Short Reports

Monomelic amyotrophy is not always benign: A case report

, , , , , , & show all
Pages 307-308 | Received 06 Jan 2011, Accepted 02 Feb 2011, Published online: 23 Feb 2011
 

Abstract

Monomelic amyotrophy (MA) is a variant of motor neuron disease (MND), characterized by muscle weakness and atrophy restricted to one limb. We describe the case of a 56-year-old Italian patient who developed a segmental muscular atrophy limited to the lower left limb. After 11 years of clinical stability he developed progressive spread of the disease to all limbs and to bulbar and respiratory muscles. The patient died from respiratory failure 15 years after disease onset. This case demonstrates that monomelic amyotrophy may rarely evolve to a diffuse fatal MND, even after more than a decade of clinical stability. Our findings support the idea that MA is part of the clinical continuum of MND.

Declaration of interest: A. Chiò serves on the editorial advisory board of Amyotrophic Lateral Sclerosis and has received research support from Ministero della Salute (Progetti Finalizzati), Regione Piemonte (Progetti Finalizzati), Ministero dell’ Università e della Ricerca (PRIN 2007), Università di Torino (fondi ex 60%), Fondazione Vialli and Mauro for ALS Research, ONLUS, and Federazione Italiana Giuoco Calcio. A. Calvo has received research support from Regione Piemonte (Progetti Finalizzati).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.